 Science's top employer ranking 2006
For the fifth consecutive year, AstraZeneca was named a “top employer” in Science magazine’s ranking of the world’s most respected biopharmaceutical employers.
October 2006
The foundation of AstraZeneca's biopharmaceuticals strategy
CAT is central to our plans to establish a major international presence in research and development of biological therapeutics
September 2006 The productivity enhancer and science driver
Once again, two of AstraZeneca’s scientific leaders have been recognised in the PharmaVOICE 100.
August 2006 Our Alliance Strategy - more than the sum of its parts
In a recent survey, AstraZeneca was found to be one of the most highly rated large life science companies as a partner and funder of academic research.
May 2006 AstraZeneca at BIO 2006
Evaluating licensing and partnering opportunities within a wide range of sciences. Active networking with stakeholders from the worlds of science, health, politics, business, and academia.
May2006 Accessing the global talent pool
Jan Lundberg, Executive Vice President, and Head of AstraZeneca Global Discovery Research participated in a Q&A session at the BIO 2006 annual international convention, April 9-12.
May 2006 COPD root causes under the spotlight
The yearly AstraZeneca COPD Symposium attracts many of the most important COPD researchers. The publication of the articles in PATS ensures that the outcome of the conference is available to researchers all over the world.
April 2006 Tackling tuberculosis
We are proud to be able to play a part in the fight against TB through our ongoing commitment to finding a new treatment for TB at our dedicated research facility in Bangalore and through our continued support to the Red Cross TB community programmes in Turkmenistan and Kyrgyzstan.
March 2006 |